PLEASANTON, Calif. & SEATTLE--(BUSINESS WIRE)--Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), and Veeva Systems (NYSE: VEEV), a leading provider of software, data, and business consulting for the life sciences industry, today announced an expansion of their long-standing collaboration. Veeva is using AWS as the cloud infrastructure for its Veeva Vault applications,...
Veeva Systems delivered a standout quarter, raising guidance and demonstrating accelerating growth, with Crossix and the company's Commercial Cloud, overall, driving strong revenue and margin outperformance. Despite macro and competitive risks, I see Veeva's competitive position strengthening, especially as migrations to Vault CRM and new AI offerings gain traction. Veeva AI, launching in Decem...
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed PLEASANTON, Calif. , June 11, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 50 medtech companies, including 11 of the top 20 medtechs and seven of the top 10 medtech clinical research organizations (CROs), have selected Veeva Clin...
Industry focused on automation, connectivity, and reporting for proactive quality management PLEASANTON, Calif. , June 9, 2025 /PRNewswire/ -- The 2025 Veeva MedTech Postmarket Quality Benchmark Report reveals that 88% of the medtech companies surveyed are advancing postmarket quality management within the next three years to improve compliance and drive innovation.
I rate Veeva Systems as a hold, as the current price is close to my new intrinsic value of $322 per share, limiting the margin of safety. Veeva's Q1 FY2026 results were outstanding, driven by Vault CRM migration, AI integration, Crossix performance, and strong SMB sector recovery. Veeva's innovation pace, deep industry specialization, and expanding AI features reinforce its moat versus Salesfor...
Veeva Systems Inc. (NYSE:VEEV ) Annual William Blair Growth Stock Conference June 4, 2025 2:20 PM ET Company Participants Brian Van Wagener - Chief Financial Officer Conference Call Participants Dylan Tyler Becker - William Blair & Company L.L.C., Research Division Dylan Tyler Becker Thank you, everybody.
Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery PLEASANTON, Calif. and NASHVILLE, Tenn.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.